Jump to content

HemoCue

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Musicalmohit (talk | contribs) at 09:58, 21 May 2019 (Sentence correction). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

HemoCue, part of the Radiometer Group, is a Swedish company headquartered in Ängelholm, Sweden. HemoCue develops, produces, and markets medical diagnostic products like hemoglobin, glucose for point-of-care testing markets worldwide.[1] HemoCue has been in the international market for more than 35 years with a presence in more than 130 countries.[2]

Worldwide 4 HemoCue tests are performed each second throughout the year.[2]

HemoCue
Company typePrivate
IndustryHealthcare
FounderJan Lilja and Sven-Erik Nilsson
HeadquartersÄngelholm,
Sweden
Area served
Worldwide
Key people
Christophe Duret(President)
ProductsPoint-of-care testing analyzers
Number of employees
450+
Websitehttps://www.hemocue.com

Radiometer is owned by Danaher Corporation, which in 2017 had an annual turnover of US$18.33 billion.

Products & Offerings

HemoCue provides various point-of-care testing analyzers to contribute to better healthcare by providing the data healthcare professionals need to help them make accurate healthcare decisions quickly.

  1. Hematology testing & white blood cell count (WBC)
    1. Hemoglobin analyzer
    2. Anemia screening analyzer
    3. Hemolysis estimation analyzer
    4. Total white blood cell count analyzer
    5. Total white blood cell count & five-part differentials count analyzer
  2. Diabetes Screening & Diagnosing
    1. Blood glucose level testing analyzer
    2. HbA1c measuring analyzer
    3. Microalbuminuria screening & testing analyzer

History

1974 - 1987

In 1974, Laboratory Engineer Jan Lilja along with Sven-Erik Nilsson, a computer expert of the Kristianstad Hospital Clinical Laboratory begin outlining an improved method for measuring haemoglobin[3] to save healthcare from inaccuracy and dangers of limited reagent durability, shifting instrument calibration, and pipetting which leads to 30-40% inaccuracy in test values.[4] After proving soundness of the method and the feasibility of microcuvette production in 1977, a license agreement with pharmaceutical company Leo was signed in 1979. In 1982, Leo starts selling and distributing the first haemoglobin meters which was later purchased by Pharmacia in 1987.[3]

1988 - 1999

HemoCue AB was formed in 1988 after the management buys out Leo Diagnostics. In 1990, HemoCue Inc. was founded in United States. In 1991, HemoCue introduced glucose system, based on the same principles as the hemoglobin system. HemoCue got owned by Mallinckrodt Inc of Saint Louis, Missouri, USA in 1992. In 1999, a private equity gorup named as EQT of northern Europe acquired HemoCue.[3]

2007 - 2013

HemoCue was acquired by Quest Diagnostics in 2007.[5] In 2013, Radiometer Medical Aps, a Danaher company acquired HemoCue.[6]


2019 -

HemoCue launches in-office hemoglobin count system - HemoCue® Hb 801 System in the U.S.[7]

References

  1. ^ "HemoCue AB: Private Company Information - Bloomberg". www.bloomberg.com. Retrieved 2018-11-14. {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  2. ^ a b "About HemoCue - Provider of Point-of-Care testing solutions". www.hemocue.com. Retrieved 2018-12-18.
  3. ^ a b c "HemoCue History and Milestones". www.hemocue.com. Retrieved 2018-11-14.
  4. ^ "The HemoCue Story - More than 35 years of accuracy". www.hemocue.com. Retrieved 2018-11-14.
  5. ^ "Quest Diagnostics | Press Release". ir.questdiagnostics.com. Retrieved 2018-11-14.
  6. ^ "Radiometer Medical acquires HemoCue". Nordic Life Science – the leading Nordic life science news service. 2013-03-04. Retrieved 2018-11-14.
  7. ^ "HemoCue launches in-office hemoglobin count system in the U.S." FierceBiotech. Retrieved 2019-05-21.